Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00998127 · ClinicalTrials.gov registry record
Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 5,031
- Enrollment target
NCT00998127 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 5,031 participants.
The verdict
NCT00998127 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 5,031 participants
- Enrollment target
Study Summary
The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following stent implantation, and to examine the relationship between specific patterns of non-adherence and patient outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,031 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00998127
The ClinicalTrials.gov registry entry for NCT00998127 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00998127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00998127 about?
NCT00998127 is a clinical study titled "Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients". The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following stent implantation, and to examine the relationship between specific patterns of non-adherence and patient outcomes.
What is the current status of trial NCT00998127?
This trial is currently completed. The enrollment target is 5,031 participants. The study started on 2009-06. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT00998127?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.